Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.

Rajamani K, Chaturvedi S, Jin Z, Homma S, Brey RL, Tilley BC, Sacco RL, Thompson JL, Mohr JP, Levine SR; PICSS-APASS Investigators.

Stroke. 2009 Jul;40(7):2337-42. doi: 10.1161/STROKEAHA.108.539171. Epub 2009 Jun 4.

2.

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.

Levine SR, Brey RL, Tilley BC, Thompson JL, Sacco RL, Sciacca RR, Murphy A, Lu Y, Costigan TM, Rhine C, Levin B, Triplett DA, Mohr JP; APASS Investigators.

JAMA. 2004 Feb 4;291(5):576-84.

PMID:
14762036
3.

Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.

Elmariah S, Furlan AJ, Reisman M, Burke D, Vardi M, Wimmer NJ, Ling S, Chen X, Kent DM, Massaro J, Mauri L; CLOSURE I Investigators.

JACC Cardiovasc Interv. 2014 Aug;7(8):913-20. doi: 10.1016/j.jcin.2014.01.170.

4.

Age as a determinant of adverse events in medically treated cryptogenic stroke patients with patent foramen ovale.

Homma S, DiTullio MR, Sacco RL, Sciacca RR, Mohr JP; PICSS Investigators.

Stroke. 2004 Sep;35(9):2145-9. Epub 2004 Jul 1.

5.

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.

Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, Venti M, Alberti A, Palmiero RA, Cerrato P, Silvestrelli G, Lanari A, Previdi P, Corea F, Balducci A, Ferri R, Falcinelli F, Filippucci E, Chiocchi P, Grandi FC, Ferigo L, Musolino R, Bersano A, Ghione I, Sacco S, Carolei A, Baldi A, Ageno W; FORI (Foramen Ovale Registro Italiano) Investigators.

Cerebrovasc Dis. 2011;31(2):109-16. doi: 10.1159/000321334. Epub 2010 Nov 17.

PMID:
21088390
6.

Stroke or transient ischemic attack in patients with transvenous pacemaker or defibrillator and echocardiographically detected patent foramen ovale.

DeSimone CV, Friedman PA, Noheria A, Patel NA, DeSimone DC, Bdeir S, Aakre CA, Vaidya VR, Slusser JP, Hodge DO, Ackerman MJ, Rabinstein AA, Asirvatham SJ.

Circulation. 2013 Sep 24;128(13):1433-41. doi: 10.1161/CIRCULATIONAHA.113.003540. Epub 2013 Aug 14.

7.

Percutaneous device closure of patent foramen ovale in patients with presumed cryptogenic stroke or transient ischemic attack: the Mayo Clinic experience.

Ford MA, Reeder GS, Lennon RJ, Brown RD, Petty GW, Cabalka AK, Cetta F, Hagler DJ.

JACC Cardiovasc Interv. 2009 May;2(5):404-11. doi: 10.1016/j.jcin.2008.12.015.

8.

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL; RESPECT Investigators.

N Engl J Med. 2017 Sep 14;377(11):1022-1032. doi: 10.1056/NEJMoa1610057.

9.

D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.

Kim YD, Song D, Nam HS, Lee K, Yoo J, Hong GR, Lee HS, Nam CM, Heo JH.

Thromb Haemost. 2015 Aug 31;114(3):614-22. doi: 10.1160/TH14-12-1040. Epub 2015 May 21.

PMID:
25994249
10.

Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.

Amory CF, Levine SR, Brey RL, Gebregziabher M, Tuhrim S, Tilley BC, Simpson AC, Sacco RL, Mohr JP; APASS-WARSS Collaborators.

Cerebrovasc Dis. 2015;40(5-6):293-300. doi: 10.1159/000441362. Epub 2015 Oct 29.

11.

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study.

Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PFO in Cryptogenic Stroke Study (PICSS) Investigators.

Circulation. 2002 Jun 4;105(22):2625-31.

12.
13.

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.

Rengifo-Moreno P, Palacios IF, Junpaparp P, Witzke CF, Morris DL, Romero-Corral A.

Eur Heart J. 2013 Nov;34(43):3342-52. doi: 10.1093/eurheartj/eht285. Epub 2013 Jul 11. Review.

PMID:
23847132
14.

Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.

Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, Erwin PJ, Tleyjeh I, Khuder S, Eltahawy EA.

JACC Cardiovasc Interv. 2013 Dec;6(12):1316-23. doi: 10.1016/j.jcin.2013.08.001. Epub 2013 Oct 16. Review.

15.

Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy.

Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP.

J Am Coll Cardiol. 2003 Sep 17;42(6):1066-72.

16.

Assessment of morphology of patent foramen ovale with transesophageal echocardiography in symptomatic and asymptomatic patients.

Bayar N, Arslan Ş, Çağırcı G, Erkal Z, Üreyen ÇM, Çay S, Köklü E, Yüksel İÖ, Küçükseymen S.

J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1282-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.036. Epub 2015 Apr 20.

PMID:
25906928
17.

Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.

Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, Mattle HP, Meier B.

J Am Coll Cardiol. 2004 Aug 18;44(4):750-8.

18.

Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.

Mirzaali M, Dooley M, Wynne D, Cooter N, Lee L, Haworth P, Saha R, Gainsborough N, Hildick-Smith D.

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):1078-84. doi: 10.1002/ccd.26080. Epub 2015 Jun 23.

PMID:
26105198
19.

Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events.

Mono ML, Geister L, Galimanis A, Jung S, Praz F, Arnold M, Fischer U, Wolff S, Findling O, Windecker S, Wahl A, Meier B, Mattle HP, Nedeltchev K.

Stroke. 2011 Oct;42(10):2891-5. doi: 10.1161/STROKEAHA.111.619577. Epub 2011 Aug 4.

20.

Sex differences in cryptogenic stroke with patent foramen ovale.

Nedeltchev K, Wiedmer S, Schwerzmann M, Windecker S, Haefeli T, Meier B, Mattle HP, Arnold M.

Am Heart J. 2008 Sep;156(3):461-5. doi: 10.1016/j.ahj.2008.04.018. Epub 2008 Jul 2.

PMID:
18760126

Supplemental Content

Support Center